Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mesoblast Ltd (NASDAQ:MESO)

4.57
Delayed Data
As of 10:05am ET
 +0.01 / +0.22%
Today’s Change
3.50
Today|||52-Week Range
10.89
-28.14%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close4.56
Today’s open4.60
Day’s range4.57 - 4.60
Volume200
Average volume (3 months)18,633
Market cap$344.9M
Dividend yield--
Data as of 10:05am ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)+96.32%
Earnings growth (this year)-791.23%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+143.13%
P/E ratio--
Price/Sales6.89
Price/Book0.65

Competitors

 Today’s
change
Today’s
% change
CFMSConforMIS Inc-0.16-1.79%
IVCInvacare Corp-0.10-0.81%
RTIXRTI Surgical Inc-0.10-3.03%
SIENSientra Inc-0.11-1.36%
Data as of 10:25am ET, 12/07/2016

Financials

Next reporting dateFebruary 27, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$41.5M
Annual profit (last year)-$4.1M
Net profit margin-9.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts


Search for Jobs